Table 4. Baseline characteristics of HIV seroconverters initiating cART by HCV status.

	HCV Negative N = 1396	HCV Positive* N = 106	Total N = 1502
Male	1322 (94.7%)	82 (77.4%)	1404 (93.5%)
Risk Group: MSM †	1253 (89.8%)	49 (46.2%)	1302 (86.7%)
MSW ††	119 (8.5%)	5 (4.7%)	124 (8.3%)
PWID †††	8 (0.6%)	51 (48.1%)	59 (3.9%)
Unknown/other	16 (1.1%)	1 (0.9%)	17 (1.1%)
Ethnicity: White	1226 (87.8%)	72 (67.9%)	1298 (86.4%)
Black African	47 (3.4%)	0 (0.0%)	47 (3.1%)
Unknown/other	123 (8.8%)	34 (32.1%)	157 (10.5%)
Years between HIV seroconversion and cART initiation: Median (IQR)	2.35 (0.76, 5.44)	7.33 (2.78, 13.47)	2.51 (0.84, 5.82)
Years HIV test interval: median (IQR)	0.58 (0.29, 0.97)	0.84 (0.38, 1.27)	0.60 (0.29, 1.00)
Year of seroconversion: Median (IQR)	2004 (1999, 2009)	1994 (1987, 2001)	2004 (1999, 2008)
Age at first cART Median (IQR)	37.11 (30.76, 44.23)	37.48 (33.55, 42.33)	37.13 (30.90, 44.04)
Baseline CD4: Median (IQR)	323.1 (242.4, 443.0)	258.7 (165.5, 370.0)	320.0 (238.5, 438.3)

*Evidence of HCV co-infection at cART initiation

^† Sex between men

^††Sex between men and women

^†††People who inject drugs